ALB

Albemarle Corp presents a distinctive cyclical profile within the chemicals sector, with systematic screening highlighting significant profitability headwinds amid modest revenue expansion. Trading at $175.74 with a market capitalization of $21.3 billion, the lithium producer operates in a sector experiencing sharp pricing volatility, reflected in the absence of trailing P/E metrics due to negative earnings of $-2.0 per share.

The fundamental data reveals pronounced margin compression across operations. Return on equity stands at -2.35%, while operating margin registers -1.78% and net margin reaches -4.24%, indicating substantial cost pressures relative to the 7.87% year-over-year revenue growth. The price-to-book ratio of 1.75 against a book value per share of $80.99 suggests the market prices shares modestly above tangible equity despite current unprofitability.

Balance sheet metrics demonstrate relative strength:

• Debt-to-equity ratio of 0.34 indicates conservative leverage positioning
• Current ratio of 2.23 provides substantial liquidity coverage
• Price-to-sales ratio of 3.84 reflects valuation compression from peak levels, given the 52-week range of $53.70 to $221.00

The elevated beta of 1.38 signals amplified sensitivity to market movements, characteristic of cyclical commodity-linked businesses. Gross margin preservation at 18.44% offers a structural foundation as operating leverage potentially inflects with lithium market stabilization.

Risk factors center on sustained negative cash generation and the commodity price cycle's uncertain trajectory. Relative to peers SHW, ECL, and PPG—which typically maintain positive profitability metrics—Albemarle's positioning reflects its concentrated exposure to battery materials rather than diversified specialty chemicals, making fundamental performance more dependent on electric vehicle adoption trajectories and global lithium supply-demand equilibrium.